XIG (FHIR Server FHIR Server Version n/a)

FHIR IG Statistics (4312 ms)

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | BNW | br | ca | ch | cl | cr | cz | de | dk | ee | efss | essilux | eu | examples | fi | fr | il | in | it | jp | nl | no | nume | nz | pt | rdsuwearme | sami | se | sl | stt | test | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16263 resources

By Version

R2: 52
R2B: 0
R3: 522
R4: 15251
R4B: 0
R5: 438
R6: 0

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.193	Oral Contraceptive Pill ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.194	Oral Contraceptive Pill ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.195	Oral Contraceptive Pill HCPCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.196	Oral Contraceptive Pill LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.197	Injectable Contraceptive Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.198	Injectable Contraceptive Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.199	Oral Contraceptive Pill Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.200	Oral Contraceptive Pill Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.201	Contraceptive Implant Devices	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.202	Contraceptive Implant Provision Procedures	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.203	Contraceptive Implant Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.204	Prenatal Care Bundle CPT	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.205	Prenatal Care Bundle Visits	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.206	Infecund Not for Contraceptive Reasons ICD10PCS Procedures	active	2022-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.209	Yes and No Answers	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.21	Contraceptive Provision Method	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.210	Pap Smear Results	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.211	Contraceptive discussion	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.22	Pregnancy Intention	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.24	Clinical Provider Role	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.29	Insurance Coverage Type	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.3	Organism Detection	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.31	English Proficiency	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.76	Contraceptive Patch RXNORM Medications	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.78	Intrauterine Devices CPT Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.79	Intrauterine Devices HCPCS Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.80	Intrauterine Devices LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.81	Intrauterine Devices HCPCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.83	Intrauterine Devices ICD10CM Provision Encounters	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.84	Intrauterine Devices ICD10CM Surveillance	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.85	Intrauterine Devices RXNORM Medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.86	Intrauterine Devices SNOMED Devices	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.87	Intrauterine Devices SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.88	Intrauterine Device SNOMED Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.89	Intrauterine Devices SNOMED Surveillance Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.91	Intrauterine Devices ICD10PCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.93	Female Sterilization CPT Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.96	Infecund Not for Contraceptive Reasons SNOMED Findings	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.97	Infecund Not for Contraceptive Reasons ICD10CM	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.98	Female Sterilization LOINC	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.99	Female Sterilization ICD10PCS Provision Procedures	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.10	ASN Screening Declined	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.11	Transportation Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.12	Food Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.13	Homelessness Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.14	Housing Instability Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.15	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.16	Intervention for Positive Food Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.17	Intervention for Positive Food Insecurity Screen	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.18	Intervention for Positive Food Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.19	Intervention for Positive Food Insecurity Screen	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.2	Intracranial or Intraspinal surgery	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.20	Intervention for Positive Homelessness Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.21	Intervention for Positive Housing Instability Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.22	Emergency Department Observation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.27	Mental Health Diagnosis without Substance Use Disorders	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.28	Mental Health Diagnosis without Substance Use Disorders	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.29	Bed Assigned	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.3	Malignant Intracranial Neoplasm Group	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.31	Healthcare Agent & Power of Attorney Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.32	Healthcare Agent and Power of Attorney Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.33	Advance Directive Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.34	Advance Directive Documentation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.35	Advance Directive Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.36	Portable Medical Order(s) Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.37	Portable Medical Order(s) Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.38	Advance Care Planning Discussion Documentation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4	Thrombolytic medications	active	2021-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.40	Advance Care Planning Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.41	Advance Care Planning Documentation	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.42	Healthcare Agent & Power of Attorney Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.43	Advance Directive Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.45	Advance Care Planning Documentation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.46	Advance Care Planning Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.47	Portable Medical Order(s) Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.48	Portable Medical Order(s) Documentation	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.49	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.5	Allergy to thrombolytics	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.50	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.51	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.52	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.53	Intervention for Positive Housing Instability Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.54	Intervention for Positive Housing Instability Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.55	Intervention for Positive Homelessness Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.56	Intervention for Positive Homelessness Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.57	Non Invasive Oxygen Therapy Device Codes	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.58	Goals, preferences, and priorities for medical treatment	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.6	Thrombolytics Adverse Event	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.7	Intraspinal surgery	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.8	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.9	Utility Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1176.58	Food Insecurity Screening Positive	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.1	Ezetimibe Therapy	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.10	Antihypertensive Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.100	Allergy or Intolerance to ACE Medication	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.101	Allergy or Intolerance to ARB Medication	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.102	Chronic Kidney Disease Stage 1	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.103	Chronic Kidney Disease Stage 2	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.104	Chronic Kidney Disease Stage 3	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.105	Chronic Kidney Disease Stage 4	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.106	Chronic Kidney Disease Stage 5	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.107	ICD10 CM Chronic Kidney Disease Stage 1	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.108	ICD10 CM Chronic Kidney Disease Stage 2	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.111	AHA GWTG Chronic Kidney Disease Stage 2	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.112	ICD10 CM Chronic Kidney Disease Stage 3	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.113	ICD10 CM Chronic Kidney Disease Stage 4	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.114	ICD10 CM Chronic Kidney Disease Stage 5	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.115	AHA GWTG Chronic Kidney Disease Stage 1	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.116	AHA GWTG Chronic Kidney Disease Stage 3	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.117	AHA GWTG Chronic Kidney Disease Stage 4	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.118	SNOMED CT Atrial Fibrillation	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.119	ICD10 CM Atrial Fibrillation	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.121	AHA GWTG Atrial Fibrillation	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.123	SNOMED CT Hyperlipidemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.124	ICD10 CM Hyperlipidemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.125	AHA GWTG Hyperlipidemia	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.126	SNOMED CT Hypertriglyceridemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.127	ICD10 CM Hypertriglyceridemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.129	AHA GWTG Hypertriglyceridemia	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.130	SNOMED CT Gestational Diabetes	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.131	ICD10 CM Gestational Diabetes	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.132	AHA GWTG Gestational Diabetes	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.133	SNOMED CT Hyperglycemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.134	ICD10 CM Hyperglycemia	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.135	AHA GWTG Hyperglycemia	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.136	SNOMED CT Nonobstructive CAD	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.137	ICD10 CM Nonobstructive Coronary Artery Disease	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.138	AHA GWTG Nonobstructive coronary artery disease	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.139	AHA GWTG Anti Obesity Pharmacotherapy	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.15	Non Tobacco Smoking Product User	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.16	Antihypertensive Fixed Dose Combination Medications	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2	PCSK9 Inhibitors	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.20	CCB and Thiazide and Thiazide Like Diuretics	active	2021-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.21	Referral to cardiac rehab	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.22	Cardiac Rehabilitation	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.25	2 Hour Blood Glucose Test	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.26	NYHA Functional Classification	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27	ARNI Therapy	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.29	MRA Therapy	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.3	Cholesterol non HDL Laboratory Test	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.30	SGLT2 Inhibitors	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.31	Heart Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.32	Heart Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.33	Heart Transplant	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.34	Allergy to MRA Therapy	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.35	Aspirin or Clopidogrel	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.39	Cardiac Rehabilitation	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.4	Hypothyroidism	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.40	Cardiac Rehabilitation	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43	SGLT2 Ingredients	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.44	MRA Ingredients	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.49	Minnesota Living with Heart Failure Questionnaire	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.5	Hypothyroidism	active	2024-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.50	Kansas City Cardiomyopathy Questionnaire	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.51	Cardiac Pacer	active	2021-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.52	Cardiac Pacer	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.53	Cardiac Pacer	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.54	Heart Transplant Complications	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.55	Heart Transplant Complications	active	2025-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.56	Heart Transplant Complications	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.57	Left Ventricular Assist Device Complications	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.58	Left Ventricular Assist Device Complications	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.59	Left Ventricular Assist Device Placement	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.6	Hypothyroidism	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.60	Left Ventricular Assist Device Placement	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.61	Left Ventricular Assist Device Placement	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.62	Left Ventricular Assist Device Placement	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.63	Heart Transplant	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.65	Cardiac Pacer	active	2022-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.66	Diastolic Heart Failure	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.67	Diastolic Heart Failure	active	2023-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.68	Diastolic Heart Failure	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.69	Allergy to SGLT2 Inhibitors	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.7	Anorexia Nervosa	active	2023-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.70	Intolerance to SGLT2 Inhibitors	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71	Intolerance to MRA Therapy	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.72	ARNI Ingredient	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.73	Mitral Stenosis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.74	Mitral Stenosis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.75	Mitral Stenosis	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.76	Mechanical Prosthetic Heart Valve	active	2022-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.77	Mechanical Prosthetic Heart Valve	active	2025-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.78	Mechanical Prosthetic Heart Valve	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.79	Mechanical Prosthetic Heart Valve in Situ	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.8	Anorexia Nervosa	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.82	Systolic Heart Failure	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.83	Systolic Heart Failure	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.84	Systolic Heart Failure	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.85	Carotid Intervention	active	2023-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.86	Serum Creatinine	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.87	Urine Creatinine	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.88	Urine Albumin	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.9	Anorexia Nervosa	active	2021-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.90	Non Steroidal Mineralcorticoid Receptor Antagonist	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.91	Glucagon like peptide 1 medications	active	2024-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.96	AHA GWTG Long COVID19	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.97	AHA GWTG Long COVID19 SNOMEDCT	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.98	AHA GWTG Long COVID19 ICD10CM	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.1	Wound internal item and/or body structure visible value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.11	Wound exudate appearance value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.12	Wound exudate color value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.13	Exudate odor value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.14	Wound anatomic location value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.16	Skin temperature value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.17	Skin color enumerated value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.18	Skin turgor value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.19	Skin and mucous membrane integrity value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.2	Periwound condition value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.20	Skin moisture value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.3	Wound Type Etiology value set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.4	Wound episode value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.6	Wound bed appearance value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.60	Wound type reference set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.7	Wound bed color value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.74	Nonverbal pain indicators reference set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.76	Pain associated signs and symptoms reference set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.77	Pain body location reference set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.8	Wound edge description value set (foundation metadata concept)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.80	Pain quality reference set	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.81	Pain speed of onset reference set	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1181.9	Presence absence value set (foundation metadata concept)	active	2018-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.1	Common drug substances for allergy and intolerance documentation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.2	Common drug classes for allergy and intolerance documentation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.3	Common dietary substances for allergy and intolerance documentation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.4	Common environmental substances for allergy and intolerance documentation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.5	Common refutations for substance causes for allergy and intolerance documentation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.7	Common substances for allergy and intolerance documentation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1186.8	Common substances for allergy and intolerance documentation including refutations	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.10	NHSNCriterionOfDiagnosisCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.11	NHSNCriterionOfDiagnosisCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.12	NHSNInfectionConditionCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.13	NHSNInfectionConditionCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.14	NHSNInfectionTypeCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.15	NHSNInfectionTypeCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.16	NHSNInfectionFirstReportedSource(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.17	NHSNInfectionFirstReportedSource(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.18	NHSNLOS/MENDischargeDisposition(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.19	NHSNLOS/MENDischargeDisposition(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.20	NHSNPopulationSummaryReportTypeCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.21	NHSNPopulationSummaryReportTypeCode(LOINC)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.22	NHSNSameDayOutcomeMeasure(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.23	NHSNSameDayOutcomeMeasure(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.24	NHSNSignificantPathogenCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.25	NHSNSignificantPathogenCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.26	NHSNSpinalFusionApproachCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.27	NHSNSpinalFusionApproachCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.28	NHSNVascularAccessTypeCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.29	NHSNVascularAccessTypeCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.30	NHSNVascularSpecimenCollectionSite(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.31	NHSNVascularSpecimenCollectionSite(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.38	Blood Glucose Laboratory and Point of Care Tests	active	2023-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.58	Diabetes Medications	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.6	NHSNPathogenCodeARO	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.62	Lab Tests for Clostridioides difficile	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.63	Bacterial and Fungal Blood Culture Tests	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.7	NHSNRoleOfPerformerCode(CDCNHSN)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.74	Enteral Medication Route	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.75	Intravenous Medication Route	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.76	Fidaxomicin	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.77	Vancomycin	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.78	Metronidazole	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.79	Fidaxomicin, Vancomycin, and Metronidazole	active	2022-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.8	NHSNRoleOfPerformerCode(SNOMEDCT)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.85	Baloxavir	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.86	Peramivir	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.87	Zanamivir	active	2023-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.88	Digestive, Intramuscular, Intravenous Route of Administration	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.89	Maternal Diagnoses	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.9	NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)	active	2020-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.90	NHSN LTC AU Antimicrobial Agents	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.91	Long Term Care Discharge Disposition	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.94	NHSNNeurogenicBladder	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1190.95	NHSNSpinalCordInjury	active	2025-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1139	S4G Hyperlipidemia	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1291	S4G Cardiomyopathy	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1292	S4G Tricuspid valve disorder	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1293	S4G Pompe disease	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1294	S4G Malignant hyperthermia	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1295	S4G Malignancy	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1297	S4G Intestinal polyp	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1298	S4G Hamartoma	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1299	S4G Diabetes mellitus	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1300	S4G Muscular dystrophy and weakness	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1325	S4G Hamartoma and S4G Intestinal Polyp	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1326	S4G Malignancy and S4G Intestinal Polyp	active	2022-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1344	Tests for Neisseria gonorrhoeae of unspecified site reported by presence	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1352	Body weight	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1354	Cefixime preparations for oral administration	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1358	Beta lactam medicinal product SNOMED	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.1370	Beta lactam ingredients for allergy determination RXNORM	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.147	SCIP Major Surgical Procedure	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158	Multiple Myeloma Regimen Drugs	active	2019-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.226	Opioids, All	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3483	Financial Insecurity Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3484	Food Insecurity Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3485	Health Literacy Screening Assessments Questions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3486	Homelessness Screening Assessments Questions	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3487	Housing Instability Screening Assessments Questions	active	2023-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3488	Less Than High School Education Screening Assessments Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3519	Health Insurance Coverage Status Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.3520	Inadequate Housing Screening Assessments And Questions	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.393	Hypoglycemics Severe Hypoglycemia	active	2024-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.394	Hypoglycemics Treatment Medications	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4436	Gentamicin medications	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4437	Azithromycin medications	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4448	Lidocaine	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4466	Pharyngeal specimens	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4467	Urogenital & Anorectal Specimens	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4469	Cabotegravir Injectable Products	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4470	Emtricitabine oral for HIV PrEP	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4474	HIV Laboratory Based Tests	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.4502	Ceftriaxone all code types	active	2024-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491	Medium Dose ICS Formoterol Preparations	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495	ICS LABA LAMA Preparations	active	2021-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.788	Social Determinants of Health Conditions	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.789	Social Determinants of Health Procedures	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.790	Social Determinants of Health Service Requests	active	2024-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.93	CPIC RxNORM abacavir SCDG	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.94	CPIC RxNORM allopurinol SCDG	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.95	CPIC RxNORM amitriptyline SCDG	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96	CPIC RxNORM atazanavir SCDG	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.97	CPIC RxNORM atomoxetine SCDG	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99	CPIC RxNORM capecitabine SCDG	active	2019-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.1	Mechanical Complications Related To Hip and Knee Procedures	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.10	Surgical Site Bleeding and Other Surgical Site Complications	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.11	Procedures Resulted From Surgical Site Bleeding and Other Surgical Site Complications	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.12	Opioid (Oral Tablets and Patches only)	active	2019-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.13	Comorbidity Risk Factors	active	2020-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.14	Treatment of Hemorrhage or Hematoma	active	2020-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.15	General Surgery	active	2020-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.17	Coagulation Disorder Conditions	active	2020-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.18	Acute Respiratory Failure	active	2020-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.19	Anticoagulant Medications	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.2	Fracture Exclusions For Hip And Knee Procedures	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.20	Anticoagulant Medications, Oral	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.21	Anticoagulant Medications, Injection	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.28	Active Bleeding	active	2020-11
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.29	Fall Risk Increasing Drugs (FRIDs)	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.3	Pulmonary Embolism Complications Related To Hip and Knee Procedures	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.30	Fall Risk Factors	active	2021-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.32	Total Hip Arthroplasty Surgery	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.33	Total Knee Arthroplasty Surgery	active	2021-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.34	AbnormalityOfGaitAndMobility	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.35	Assymetry Symptoms	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.36	Hemiplegia Symptoms	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.37	Leg Weakness Symptoms	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.38	Osteopenia Symptoms	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.39	Stroke Symptoms	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.4	Sepsis Complications Related To Hip and Knee Procedures	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.40	Vestibular Symptoms	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.41	TricyclicAntidepressants	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.42	Benzodiazepines	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.43	LoopDiuretics	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.44	Antiepileptics	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.45	Antipsychotics	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.46	Opioid Medications	active	2021-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.47	Imaging Related to VTE	active	2023-01
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.48	Anticoagulant Medication	active	2024-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.49	VTE Diagnoses	active	2025-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.5	Nonprimary Total Hip, Total Knee Replacement	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.50	Bisphosphonate Therapy	active	2022-02
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.51	VTE Symptoms	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.52	Oncology Critical Care Units	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.53	Provider Types	active	2022-05
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56	FOBT_Lab	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.57	Colorectal Screening	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.58	Screening Mammogram (CPT)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.59	Screening Mammogram (LOINC)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.6	Pneumonia Complications Related To Hip and Knee Procedures	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.60	Screening Mammogram (SNOMEDCT)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.61	Screening Mammogram (Grouping)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.62	Diagnostic Mammography (CPT)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.63	Diagnostic Mammography (LOINC)	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.64	Diagnostic Mammography (SNOMEDCT)	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.65	Diagnostic Mammography	active	2024-08
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.66	Breast Cancer Biopsy and Surgical Excision	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.67	BI_RADS Categories 0, 4, and 5	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.68	BI_RADS Categories 1, 2, and 3	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.7	Malignant Neoplasm Complications Related To Hip and Knee Procedures	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.8	Periprosthetic Joint Infection/Wound Infection and Other Wound Complications	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.9	Procedures Resulted From Periprosthetic Joint Infection/Wound Infections	active	2019-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.101	Local Anesthetics	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.102	Ophthalmic Epinephrines	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.103	Inhaled Epinephrines	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.104	Clopidogrels	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.105	Cytochrome P450 2C19 inhibitors	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.106	Cytochrome P450 2C9 inhibitors	active	2023-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.107	Aspirin Ingredient and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109	Oral Anticoagulant Ingredients and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.110	Corticosteroid Ingredients and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.111	Antidepressant Ingredients and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.112	PPI and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113	Antiplatelet Ingredients and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.114	NSAIDs Ingredients and Risk of GI Bleeding	active	2023-12
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.115	Kratom containing compounds	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117	Clopidogrel Ingredients and Risk of GI Bleeding	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.121	Gastrointestinal bleeding episode and Risk of GI Bleeding 1	active	2024-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.122	Gastrointestinal bleeding episode and Risk of GI Bleeding 2	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.123	Gastrointestinal bleeding episode and Risk of GI Bleeding	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.24	Oxycodones	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1217.2	TESTSemanticBitsValueSet	active	2020-10
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.1	Bronchiectasis Disorder SNOMED	active	2020-04
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.10	Interstitial Lung Disease ICD10CM	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.100	Occupational Therapy Procedure HCPCS	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.101	Occupational Therapy Procedure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.102	Speech Language Therapy Procedure HCPCS	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.103	Speech Language Therapy Procedure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.104	Home Health Procedure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.105	Intermittent Skilled Nursing Home Health Procedure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.106	pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.107	Breathing Test Procedure During Sleep	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.108	Ambulance Transport Procedure	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.109	Prefabricated Spinal Orthotic Device	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.11	Interstitial Lung Disease SNOMEDCT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.110	Custom Fitted Spinal Orthotic Device	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.111	Custom Fabricated Spinal Orthotic Device	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.112	Orthotic Device Supply	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.113	Spinal Orthotic Device or Supply	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.115	Spine or Neck Disorder SNOMED CT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.116	Spine or Neck Disorder ICD10CM	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.117	Spine or Neck Disorder	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.118	Total Electric Hospital Bed Supply	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.119	Hypoventilation Disorder SNOMEDCT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.12	Interstitial Lung Disease	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.120	Hypoventilation Disorder ICD10CM	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.121	Hypoventilation Disorder	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.122	Respiratory Assist Device Qualifying Condition	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.123	Apnea Hypopnea Index Rate Measurement	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.124	Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.125	Maximal Inspiratory Pressure Measurement	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.126	Forced Vital Capacity (FVC) Measurement by Spirometry	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.127	Oxygen Saturation Measurement At Rest	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.128	Respiratory Assist Device	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.129	Respiratory Assist Device Supply	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.13	Cystic Fibrosis Lung Disease ICD10CM	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.130	Home Oxygen Therapy Accessory	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.131	Forced Vital Capacity (FVC) Measurement Prediction	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.132	Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.133	Respiratory Disturbance Index	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.134	Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.135	Past Medical History Condition Related to Need for Positive Airway Pressure Device	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.136	Home or Facility Care Location	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.137	Fracture of Bone Disorder SNOMED CT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.138	Fracture of Bone Disorder ICD10CM	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.139	Fracture of Bone Disorder	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.14	Cystic Fibrosis Lung Disease SNOMEDCT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.140	Severe Obesity Disorder SNOMED CT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.141	Severe Obesity Disorder ICD10CM	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.142	Severe Obesity Disorder	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.143	Transfer from Bed Impairment SNOMED CT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.144	Bed Confinement Impairment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.145	Transfer from Bed Impairment	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.146	Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT	active	2022-03
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.147 http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1024	Unsaturated Fat Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1025	Saturated Fat Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1026	Carbohydrate Intake	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1027	Salt Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1028	Vegetable Intake	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1029	Fruit Intake	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.103	PostTraumatic Stress Disorder PTSD	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1030	English Proficiency	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.104	PostTraumatic Stress Disorder PTSD ICD10	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1042	Neglect	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1048	Current or Former Occupation	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.105	PostTraumatic Stress Disorder PTSD SCT	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1050	Work Productivity	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1053	Income Level	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1057	Caregiver Characteristics	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1058	Caregiver Availability	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1060	Living Situation	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1064	Marital or Spousal Status	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1065	Dependents in Home	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1068	Physical Activity Level	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1069	Leisure Activity Engagement	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1075	Exposure to Environmental Hazards	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1076	Neighborhood Safety	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1080	Experiences of Discrimination	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1082	Criminal Justice Involvement or Incarceration	active	2023-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1083	Immigration Status	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.111	Creatinine in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.113	Blood Urea Nitrogen	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.114	Hemoglobin	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.118	Iron Saturation (Transferrin Saturation/TSAT)	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.119	Hemoglobin A1C	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1197	Sleep Behavior	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.120	Potassium in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1203	Medication Literacy	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1213	Elder and Child Abuse SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.122	Corrected Calcium	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1229	Education Level SCT	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.123	Phosphorus in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.126	Vitamin D Levels	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.128	KT/V Hemodialysis Ratio	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1281	Elder and Child Abuse	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.129	Intact Parathyroid Hormone	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.130	Bicarbonate in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.131	Sodium in blood, serum or plasma	active	2024-09
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.132	Chloride in blood, serum or plasma	active	2024-06
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1336	Elder and Child Abuse ICD10	active	2024-07
us.nlm.vsac	R4	http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.135	High Density Lipoprotein	active	2024-07

XIG built as of 24 Jun 2025. Found 77087 resources in 1235 packages.